Page last updated: 2024-10-18

dihydroxyphenylalanine and Liver Steatosis

dihydroxyphenylalanine has been researched along with Liver Steatosis in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knoblauch, M1
Lämmli, J1
Funk, C1
Chia, KM1

Reviews

1 review available for dihydroxyphenylalanine and Liver Steatosis

ArticleYear
[New development in the study of infectious hepatitis].
    Zhonghua yi xue za zhi, 1973, Volume: 3

    Topics: Acute Disease; Acute Kidney Injury; Alkalosis; Ammonia; Clinical Enzyme Tests; Dihydroxyphenylalanin

1973

Other Studies

1 other study available for dihydroxyphenylalanine and Liver Steatosis

ArticleYear
[Drug-induced liver diseases].
    Gastroenterologische Fortbildungskurse fur die Praxis, 1975, Volume: 5

    Topics: Acetaminophen; Adult; Alcoholism; Azathioprine; Bilirubin; Chemical and Drug Induced Liver Injury; C

1975